Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

SRPT holding history

Sarepta Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SRPT overviewAll 13F holders of SRPTFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of SRPT by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−474,986−100.0%Sold outHolders
Q1 2026474,986$10.3M<0.1%−1,065,404−69.2%ReducedHolders
Q4 20251,540,390$33.1M<0.1%−466,635−23.3%ReducedHolders
Q3 20252,007,025$38.7M<0.1%−2,471,613−55.2%ReducedHolders
Q2 20254,478,638$76.6M0.1%+4,474,232+101,548.6%AddedHolders
Q1 20254,406$281.2K<0.1%+906+25.9%AddedHolders
Q4 20243,500$425.6K<0.1%−18,239−83.9%ReducedHolders
Q3 202421,739$2.71M<0.1%−96,101−81.6%ReducedHolders
Q2 2024117,840$18.6M<0.1%+30,974+35.7%AddedHolders
Q1 202486,866$11.2M<0.1%−268,667−75.6%ReducedHolders
Q4 2023355,533$34.3M<0.1%+263,375+285.8%AddedHolders
Q3 202392,158$11.2M<0.1%−182,761−66.5%ReducedHolders
Q2 2023274,919$31.5M<0.1%−576,818−67.7%ReducedHolders
Q1 2023851,737$117.4M0.2%+269,490+46.3%AddedHolders
Q4 2022582,247$75.4M0.1%−50,614−8.0%ReducedHolders
Q3 2022632,861$70.0M0.1%+371,378+142.0%AddedHolders
Q2 2022261,483$19.6M<0.1%−29,925−10.3%ReducedHolders
Q1 2022291,408$22.8M<0.1%−66,687−18.6%ReducedHolders
Q4 2021358,095$32.2M<0.1%+270,097+306.9%AddedHolders
Q3 202187,998$8.14M<0.1%+65,680+294.3%AddedHolders
Q2 202122,318$1.74M<0.1%+8,732+64.3%AddedHolders
Q1 202113,586$1.01M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.